Twitxy Saved

Giving at UCL

@UCLGiving

We bring together visionary supporters at @UCL to change the world. #HereItWillHappen
London, UK ucl.ac.uk/giving Joined September 2016
291 Following 977 Followers 2.2K Posts

Latest posts 5

Giving at UCL @UCLGiving
The @ucl_GBSH has received approval to establish a new education hub in Dubai. As the first business school dedicated to health, it will expand access to executive and postgraduate healthcare education across the Gulf, Africa, and South Asia.

Read more: bit.ly/4kAbvy2
www.ucl.ac.uk UCL receives licence for Dubai education hub | UCL News The UCL Global Business School for Health has received approval from the UAE to establish a health-focused education hub in Dubai.
Giving at UCL @UCLGiving
UCL's Queen Square Brain Bank turns 40 years today 💜

Discoveries here have deepened our understanding of the brain – and it all starts with the people who choose to donate their brains to research.

Read more in #PorticoMagazine👇 bit.ly/4eLocBC
#HereItWillHappen
magazine.ucl.ac.uk Unlocking the secrets of the brain | Portico Magazine | UCL The 3,000 donated brains in Queen Square Brain Bank could hold the key to unlocking the secrets of dementia. But how do they get there? And what happens next?
Giving at UCL @UCLGiving
We're really pleased that Professor Selina Wray is our new Vice-Dean (Advancement)!

Professor Wray is a world-leading neuroscientist. In her new role, Professor Wray will build opportunities for alumni and philanthropic engagement that support our research and students.
Giving at UCL @UCLGiving
UCL-led STAMPEDE research suggests a genomic test could help doctors personalise treatment for prostate cancer, identifying those who would benefit from additional treatment and potentially sparing others the side effects.

👇 bit.ly/4ziLbgm
www.ucl.ac.uk Diagnostic test could help doctors refine prostate cancer treatment | UCL News New findings from the UCL-led STAMPEDE Trial may help to identify which men with high-risk prostate cancer could benefit from additional treatment and which patients could be spared side-effects.